Prognostic factors and markers of activity in multiple myeloma: Results of the Cooperative Group for Diagnostic and Treatment of Multiple Myeloma

Abstract

Multiple myeloma, overall survival, disease-free survival, beta-2-microglobulin, IL-6, sIL-6R, MGUS, prognosis, IFN-alfa, ASCT, CD20